SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3n2c'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CLA_A_CLMA221_0
(TYPE III
CHLORAMPHENICOL
ACETYLTRANSFERASE)
3n2c PROLIDASE
(unidentified)
5 / 10 THR A 224
ALA A 222
LEU A 134
VAL A 166
ILE A 215
None
None
KCX  A 188 ( 3.9A)
None
None
1.25A 1claA-3n2cA:
undetectable
1claA-3n2cA:
16.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1N2X_A_SAMA401_0
(S-ADENOSYL-METHYLTRA
NSFERASE MRAW)
3n2c PROLIDASE
(unidentified)
5 / 12 THR A 246
GLY A 250
VAL A 314
TYR A 225
ASN A 359
None
1.24A 1n2xA-3n2cA:
undetectable
1n2xA-3n2cA:
22.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Q23_E_FUAE706_1
(CHLORAMPHENICOL
ACETYLTRANSFERASE)
3n2c PROLIDASE
(unidentified)
5 / 10 PHE A 334
LEU A 378
VAL A 376
PHE A  59
VAL A 389
None
1.48A 1q23E-3n2cA:
undetectable
1q23E-3n2cA:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Q23_K_FUAK712_1
(CHLORAMPHENICOL
ACETYLTRANSFERASE)
3n2c PROLIDASE
(unidentified)
5 / 10 PHE A 334
LEU A 378
VAL A 376
PHE A  59
VAL A 389
None
1.38A 1q23K-3n2cA:
undetectable
1q23K-3n2cA:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T86_A_CAMA1422_0
(CYTOCHROME P450-CAM)
3n2c PROLIDASE
(unidentified)
4 / 8 THR A 351
THR A  54
LEU A  14
VAL A 389
None
0.75A 1t86A-3n2cA:
undetectable
1t86A-3n2cA:
23.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UWH_A_BAXA1723_2
(B-RAF PROTO-ONCOGENE
SERINE/THREONINE-PRO
TEIN KINASE)
3n2c PROLIDASE
(unidentified)
5 / 6 ILE A 357
VAL A 358
ILE A 367
ILE A  27
ASP A 374
None
0.97A 1uwhA-3n2cA:
undetectable
1uwhA-3n2cA:
18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2AVV_A_MK1A901_3
(POL POLYPROTEIN)
3n2c PROLIDASE
(unidentified)
6 / 12 ASP A 105
GLY A 108
ALA A 109
ASP A 110
ILE A  91
ILE A 127
None
1.48A 2avvB-3n2cA:
undetectable
2avvB-3n2cA:
12.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FN1_A_SALA506_1
(SALICYLATE
SYNTHETASE, IRP9)
3n2c PROLIDASE
(unidentified)
5 / 11 ILE A 357
GLY A 319
THR A 271
HIS A  63
GLY A 317
None
None
None
ZN  A 425 (-3.3A)
None
1.25A 2fn1A-3n2cA:
undetectable
2fn1A-3n2cA:
23.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FN1_B_SALB503_1
(SALICYLATE
SYNTHETASE, IRP9)
3n2c PROLIDASE
(unidentified)
5 / 11 ILE A 357
GLY A 319
THR A 271
HIS A  63
GLY A 317
None
None
None
ZN  A 425 (-3.3A)
None
1.25A 2fn1B-3n2cA:
undetectable
2fn1B-3n2cA:
23.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PGR_A_DCFA501_1
(ADENOSINE DEAMINASE)
3n2c PROLIDASE
(unidentified)
5 / 12 HIS A  63
HIS A  65
ILE A 162
HIS A 249
ASP A 321
ZN  A 425 (-3.3A)
ZN  A 425 ( 3.3A)
None
ZN  A 426 ( 3.8A)
ZN  A 425 ( 2.9A)
1.17A 2pgrA-3n2cA:
18.5
2pgrA-3n2cA:
21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VH3_A_DAHA2_1
(RANASMURFIN)
3n2c PROLIDASE
(unidentified)
5 / 9 ALA A  84
ALA A  77
GLY A 107
SER A  69
ALA A  68
None
1.33A 2vh3A-3n2cA:
undetectable
2vh3A-3n2cA:
14.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XKK_E_MFXE1100_1
(TOPOISOMERASE IV
DNA)
3n2c PROLIDASE
(unidentified)
3 / 3 ARG A 337
GLU A 356
SER A 320
None
0.90A 2xkkA-3n2cA:
undetectable
2xkkC-3n2cA:
undetectable
2xkkA-3n2cA:
21.48
2xkkC-3n2cA:
21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2XRZ_A_ACTA1470_0
(DEOXYRIBODIPYRIMIDIN
E PHOTOLYASE)
3n2c PROLIDASE
(unidentified)
4 / 5 ARG A 173
ALA A 214
ASP A 217
GLU A 218
None
1.12A 2xrzA-3n2cA:
undetectable
2xrzA-3n2cA:
22.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3D1Z_B_017B201_2
(HIV-1 PROTEASE)
3n2c PROLIDASE
(unidentified)
5 / 12 ASP A 105
GLY A 108
ALA A 109
ILE A  91
ILE A 127
None
1.03A 3d1zB-3n2cA:
undetectable
3d1zB-3n2cA:
12.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3E23_A_SAMA221_0
(UNCHARACTERIZED
PROTEIN RPA2492)
3n2c PROLIDASE
(unidentified)
5 / 12 LEU A 272
TYR A 275
GLY A 302
LEU A 306
HIS A 249
None
LWY  A 427 ( 4.7A)
None
None
ZN  A 426 ( 3.8A)
1.04A 3e23A-3n2cA:
undetectable
3e23A-3n2cA:
21.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HGI_A_BEZA284_0
(CATECHOL
1,2-DIOXYGENASE)
3n2c PROLIDASE
(unidentified)
5 / 12 VAL A 295
ILE A 202
GLY A 194
HIS A 249
HIS A 229
None
None
LWY  A 427 (-3.5A)
ZN  A 426 ( 3.8A)
ZN  A 426 ( 3.2A)
0.95A 3hgiA-3n2cA:
undetectable
3hgiA-3n2cA:
20.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NU3_B_478B401_2
(PROTEASE)
3n2c PROLIDASE
(unidentified)
6 / 11 ASP A 105
ALA A 109
ASP A 110
ILE A  91
PRO A 125
ILE A 127
None
1.16A 3nu3B-3n2cA:
undetectable
3nu3B-3n2cA:
12.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NU3_B_478B401_2
(PROTEASE)
3n2c PROLIDASE
(unidentified)
6 / 11 ASP A 105
GLY A 108
ALA A 109
ILE A  91
PRO A 125
ILE A 127
None
0.96A 3nu3B-3n2cA:
undetectable
3nu3B-3n2cA:
12.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TWP_B_SALB404_1
(ANTHRANILATE
PHOSPHORIBOSYLTRANSF
ERASE)
3n2c PROLIDASE
(unidentified)
4 / 7 ALA A 256
ARG A 234
ALA A 237
ARG A 241
None
1.10A 3twpB-3n2cA:
undetectable
3twpB-3n2cA:
25.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TWP_C_SALC404_1
(ANTHRANILATE
PHOSPHORIBOSYLTRANSF
ERASE)
3n2c PROLIDASE
(unidentified)
4 / 7 ALA A 256
ARG A 234
ALA A 237
ARG A 241
None
1.07A 3twpC-3n2cA:
undetectable
3twpC-3n2cA:
25.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U9F_I_CLMI221_1
(CHLORAMPHENICOL
ACETYLTRANSFERASE)
3n2c PROLIDASE
(unidentified)
5 / 10 PHE A 334
LEU A 378
VAL A 376
PHE A  59
VAL A 389
None
1.46A 3u9fI-3n2cA:
undetectable
3u9fI-3n2cA:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U9F_J_CLMJ221_0
(CHLORAMPHENICOL
ACETYLTRANSFERASE)
3n2c PROLIDASE
(unidentified)
5 / 12 PHE A 334
LEU A 378
VAL A 376
PHE A  59
VAL A 389
None
1.35A 3u9fJ-3n2cA:
undetectable
3u9fK-3n2cA:
undetectable
3u9fJ-3n2cA:
19.85
3u9fK-3n2cA:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3U9F_R_CLMR221_0
(CHLORAMPHENICOL
ACETYLTRANSFERASE)
3n2c PROLIDASE
(unidentified)
5 / 10 PHE A 334
LEU A 378
VAL A 376
PHE A  59
VAL A 389
None
1.42A 3u9fR-3n2cA:
undetectable
3u9fR-3n2cA:
19.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VYW_C_SAMC401_1
(MNMC2)
3n2c PROLIDASE
(unidentified)
4 / 6 GLY A 319
GLU A 333
ASP A 321
ASN A 251
None
None
ZN  A 425 ( 2.9A)
None
0.93A 3vywC-3n2cA:
undetectable
3vywC-3n2cA:
21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ACA_C_DXCC1475_0
(TRANSLATION
ELONGATION FACTOR
SELB)
3n2c PROLIDASE
(unidentified)
4 / 8 ILE A 187
ILE A 215
VAL A 166
GLY A 171
KCX  A 188 ( 3.6A)
None
None
None
0.70A 4acaC-3n2cA:
3.3
4acaC-3n2cA:
22.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ACB_C_DXCC1475_0
(TRANSLATION
ELONGATION FACTOR
SELB)
3n2c PROLIDASE
(unidentified)
4 / 8 ILE A 187
ILE A 215
VAL A 166
GLY A 171
KCX  A 188 ( 3.6A)
None
None
None
0.77A 4acbC-3n2cA:
3.2
4acbC-3n2cA:
22.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FFW_A_715A801_1
(DIPEPTIDYL PEPTIDASE
4)
3n2c PROLIDASE
(unidentified)
5 / 12 GLY A 317
VAL A 295
TYR A 275
ASN A 251
VAL A 298
None
None
LWY  A 427 ( 4.7A)
None
None
1.20A 4ffwA-3n2cA:
undetectable
4ffwA-3n2cA:
21.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L4A_A_CAMA502_0
(CAMPHOR
5-MONOOXYGENASE)
3n2c PROLIDASE
(unidentified)
4 / 8 THR A 351
THR A  54
LEU A  14
VAL A 389
None
0.75A 4l4aA-3n2cA:
undetectable
4l4aA-3n2cA:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L4D_A_CAMA503_0
(CAMPHOR
5-MONOOXYGENASE)
3n2c PROLIDASE
(unidentified)
4 / 8 THR A 351
THR A  54
LEU A  14
VAL A 389
None
0.73A 4l4dA-3n2cA:
undetectable
4l4dA-3n2cA:
23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L4E_A_CAMA503_0
(CAMPHOR
5-MONOOXYGENASE)
3n2c PROLIDASE
(unidentified)
4 / 8 THR A 351
THR A  54
LEU A  14
VAL A 389
None
0.68A 4l4eA-3n2cA:
undetectable
4l4eA-3n2cA:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4L4F_A_CAMA503_0
(CAMPHOR
5-MONOOXYGENASE)
3n2c PROLIDASE
(unidentified)
4 / 8 THR A 351
THR A  54
LEU A  14
VAL A 389
None
0.69A 4l4fA-3n2cA:
undetectable
4l4fA-3n2cA:
22.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4M11_A_MXMA606_1
(PROSTAGLANDIN G/H
SYNTHASE 2)
3n2c PROLIDASE
(unidentified)
5 / 12 MET A  56
LEU A  12
VAL A 388
LEU A 378
LEU A 383
None
1.39A 4m11A-3n2cA:
undetectable
4m11A-3n2cA:
21.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NJU_A_TPVA500_2
(PROTEASE)
3n2c PROLIDASE
(unidentified)
5 / 10 ASP A 105
ALA A 109
ILE A  91
PRO A 125
ILE A 127
None
0.77A 4njuB-3n2cA:
undetectable
4njuB-3n2cA:
12.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NJU_C_TPVC500_2
(PROTEASE)
3n2c PROLIDASE
(unidentified)
5 / 10 ASP A 105
ALA A 109
ILE A  91
PRO A 125
ILE A 127
None
0.77A 4njuD-3n2cA:
undetectable
4njuD-3n2cA:
12.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ODO_B_FK5B203_2
(PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
SLYD)
3n2c PROLIDASE
(unidentified)
3 / 3 ALA A 239
GLN A 136
GLY A 138
None
0.63A 4odoC-3n2cA:
undetectable
4odoC-3n2cA:
19.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TXN_A_URFA302_1
(URIDINE
PHOSPHORYLASE)
3n2c PROLIDASE
(unidentified)
5 / 7 GLY A 131
GLN A 186
MET A 227
ALA A 109
ILE A 127
None
None
KCX  A 188 ( 4.5A)
None
None
1.44A 4txnA-3n2cA:
undetectable
4txnA-3n2cA:
24.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TXN_B_URFB302_1
(URIDINE
PHOSPHORYLASE)
3n2c PROLIDASE
(unidentified)
5 / 7 GLY A 131
GLN A 186
MET A 227
ALA A 109
ILE A 127
None
None
KCX  A 188 ( 4.5A)
None
None
1.45A 4txnB-3n2cA:
undetectable
4txnB-3n2cA:
24.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TXN_C_URFC302_1
(URIDINE
PHOSPHORYLASE)
3n2c PROLIDASE
(unidentified)
5 / 7 GLY A 131
GLN A 186
MET A 227
ALA A 109
ILE A 127
None
None
KCX  A 188 ( 4.5A)
None
None
1.45A 4txnC-3n2cA:
undetectable
4txnC-3n2cA:
24.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TXN_D_URFD302_1
(URIDINE
PHOSPHORYLASE)
3n2c PROLIDASE
(unidentified)
5 / 7 GLY A 131
GLN A 186
MET A 227
ALA A 109
ILE A 127
None
None
KCX  A 188 ( 4.5A)
None
None
1.45A 4txnD-3n2cA:
undetectable
4txnD-3n2cA:
24.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UBP_C_HAEC800_1
(PROTEIN (UREASE
(CHAIN C)))
3n2c PROLIDASE
(unidentified)
5 / 6 HIS A  63
HIS A  65
HIS A 229
HIS A 249
ASP A 321
ZN  A 425 (-3.3A)
ZN  A 425 ( 3.3A)
ZN  A 426 ( 3.2A)
ZN  A 426 ( 3.8A)
ZN  A 425 ( 2.9A)
0.72A 4ubpC-3n2cA:
18.3
4ubpC-3n2cA:
23.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5C0O_G_SAMG301_0
(TRNA
(ADENINE(58)-N(1))-M
ETHYLTRANSFERASE
TRMI)
3n2c PROLIDASE
(unidentified)
5 / 12 GLY A 108
GLY A 131
LEU A 113
ALA A 163
ARG A 164
None
0.92A 5c0oG-3n2cA:
undetectable
5c0oG-3n2cA:
22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5E5K_B_017B201_1
(HIV-1 PROTEASE)
3n2c PROLIDASE
(unidentified)
6 / 12 ASP A 105
ALA A 109
ASP A 110
ILE A  91
PRO A 125
ILE A 127
None
1.31A 5e5kA-3n2cA:
undetectable
5e5kA-3n2cA:
11.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5E5K_B_017B201_1
(HIV-1 PROTEASE)
3n2c PROLIDASE
(unidentified)
6 / 12 ASP A 105
GLY A 108
ALA A 109
ILE A  91
PRO A 125
ILE A 127
None
1.06A 5e5kA-3n2cA:
undetectable
5e5kA-3n2cA:
11.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5Z6J_A_FOLA201_1
(DIHYDROFOLATE
REDUCTASE)
3n2c PROLIDASE
(unidentified)
3 / 3 MET A 190
ASP A 200
ARG A 144
KCX  A 188 ( 3.8A)
None
None
1.17A 5z6jA-3n2cA:
undetectable
5z6jA-3n2cA:
16.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DIF_B_TPVB201_1
(HIV-1 PROTEASE)
3n2c PROLIDASE
(unidentified)
6 / 12 ASP A 105
GLY A 108
ALA A 109
ILE A  91
PRO A 125
ILE A 127
None
0.94A 6difB-3n2cA:
undetectable
6difB-3n2cA:
10.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DIL_B_TPVB201_1
(HIV-1 PROTEASE)
3n2c PROLIDASE
(unidentified)
6 / 12 ASP A 105
GLY A 108
ALA A 109
ILE A  91
PRO A 125
ILE A 127
None
0.96A 6dilB-3n2cA:
undetectable
6dilB-3n2cA:
10.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EMU_C_SAMC301_0
(TRNA
(GUANINE(9)-/ADENINE
(9)-N1)-METHYLTRANSF
ERASE)
3n2c PROLIDASE
(unidentified)
5 / 12 GLY A 108
THR A 159
VAL A 122
VAL A 117
ILE A 127
None
1.07A 6emuC-3n2cA:
2.1
6emuC-3n2cA:
19.60